Science Applications International Corp (SAIC) Form 10-Q — Aug 31, 2026
Science Applications International Corp filed its fiscal 2027 second-quarter 10-Q reporting revenues of $1.88 billion, up 6% year over year (5.3% organic), with operating income of $152 million at an 8.1% margin. Net income fell 20% to $102 million and diluted EPS was $2.38 versus $2.71, largely because the prior-year quarter included a $47 million tax benefit from an IRS audit settlement. For the six months ended July 31, 2026, revenues rose 4% to $3.79 billion, net income climbed 11% to $217 million, diluted EPS was $5.00 versus $4.12, and operating cash flow improved to $273 million from $222 million.
Key figures
- Eps
- Q2 diluted $2.38 (vs $2.71 prior year); six-month diluted $5.00 (vs $4.12 prior year)
- Revenue
- Q2 FY2027: $1,880M (+6% YoY); six months: $3,786M (+4% YoY)
- Net Income
- Q2 $102M (-20% YoY); six months $217M (+11% YoY)
- Total Debt
- $2,485M ($33M current portion + $2,452M long-term)
- Revenue Yoy
- +6% for the quarter (5.3% organic); +4% for six months (2.9% organic)
- Cash Position
- $126M as of July 31, 2026 (vs $182M at January 30, 2026)
- Shares Outstanding
- 41897635
- Employees
- approximately 23,000 across approximately 1,700 active contracts and task orders
- Total backlog
- $22,136M as of July 31, 2026 (vs $22,622M at January 30, 2026)
- Funded backlog
- $3,818M
- Net bookings q2
- $1.2 billion
- Adjusted ebitda q2
- $193M (10.3% of revenues vs $185M prior year)
- Quarterly dividend
- $0.37 per share
- Operating income q2
- $152M (8.1% of revenues vs 7.9% prior year)
- Marpa facility limit
- increased from $300M to $400M on August 14, 2026
- Share repurchases q2
- 881,913 shares at average price of $102.60
- Effective tax rate q2
- 14.2%
- Gain on investment sale
- $12M (Q1 FY2027, $15M cash proceeds)
- Net bookings six months
- $3.3 billion
- Silveredge purchase price
- $202 million net of $6 million cash acquired (October 15, 2025)
- Us government revenue pct
- 97% of revenues
- Adjusted operating income q2
- $191M (10.2% of revenues vs 10.3% prior year)
- Share repurchases six months
- approximately 2.7 million shares for approximately $265 million
- Cumulative buyback under plan
- approximately 31.2 million shares for approximately $2.8 billion
- Operating cash flow six months
- $273M (vs $222M prior year)
- Silveredge revenue contribution
- $20M in Q2; $39M in six months
- Remaining performance obligations
- $6.4 billion (~75% expected to convert to revenue within 12 months)
Price after filing
Close on the filing date to close N calendar days later (from $125.96). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.